Users online: 1185    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 5
First page : ( 2359) Last page : ( 2365)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00424.2

Formulation and Pharmacodynamic Evaluation of Quetiapine Solid Dispersions using Plasdone K-29/32 as Carrier

Sandeep Doppalapudi*, Vidyadhara Suryadevara, Sailaja Yallam, Bhavana Pamulapati, Haritha Cherukuru, Teja Devarakonda Kalyana

Department of Pharmaceutics, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chandramoulipuram, Chowdavaram, Guntur, Andhra Pradesh, India-522019

*Corresponding Author E-mail: pharmacydeepu@gmail.com

Online published on 16 June, 2020.


The current research focuses on solubility enhancement of poorly water soluble Biopharmaceutical Classification System (BCS) class-II drug Quetiapine, using carrier like plasdone K-29/32 and to evaluate its pharmacodynamic properties. Quetiapine solid dispersions were prepared using plasdone K-29/32 in different ratios by physical mixing and solvent evaporation techniques. Various physical parameters and invitro dissolution studies were performed for the prepared solid dispersions to find out the optimized formulation. The best formulation obtained was subjected to anti-anxiety and anti-schizophrenic activities by open field test and Morris water maze methods respectively on albino mice. The physical parameters evaluated for various Quetiapine solid dispersions were evaluated which were found to be in Indian Pharmacopoeial limits. From invitro dissolution studies, it was observed that the solid dispersion formulation QTS2 containing Quetiapine and plasdone K-29/32 in 1: 1 ratios prepared by solvent evaporation technique showed higher dissolution rate in less time when compared to all other formulations. QTS2 treated albino mice when subjected to open field test showed greater line crossings and less freezing time indicating its anti-anxiety effect. Whereas QTS2 treated mice when subjected to Morris water maze, have showed enhanced cognition which was indicated by faster identification of the maze immersed in water. This proves the positive effect of Quetiapine solid dispersions against negative symptoms of schizophrenic. Thus the solid dispersions prepared using plasdone K-29/32 as carrier enhanced solubility of Quetiapine which also increased its pharmacodynamic efficacy.



Quetiapine, Plasdone K-29/32, atropine, anxiety, schizophrenia.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
598,057,469 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.